Pila Pharma Danmark ApS: Financial statements 2023
CVR: 39023636
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pila Pharma Danmark ApS (CVR 39023636) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -4,374,351 and a net result of DKK -3,817,180 compared with DKK -10,823,402 the year before. Equity in the 2023 report amounted to DKK 1,430,402. The solvency ratio was 68.6%.
- Gross Profit
- DKK -4,374,351
- Profit/Loss
- DKK -3,817,180
- Equity
- DKK 1,430,402
- Total Assets
- DKK 2,083,935
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -4.4M | -3.8M | 1.4M | - |
| 2022 | - | -13.4M | -10.8M | 3M | - |
| 2021 | - | -6.4M | -5.1M | 1.3M | - |
| 2020 | - | -3.5M | -2.8M | 854K | 0 |
| 2019 | - | -2.4M | -2.1M | 909K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pila Pharma Danmark ApS has published its annual report for 2022. Gross profit came to DKK -13,423,297, and the net result was DKK -10,823,402.
About Pila Pharma Danmark ApS
Pila Pharma Danmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Dorte Xenia Gram. The company is owned by Pila Pharma AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,798,283 and a net result of DKK -3,780,896 compared with DKK -3,094,589 the year before. Equity in the 2025 report amounted to DKK 2,596,207.